APA (7th ed.) Citation

A, B., M, K., L, M., C, W., CA, F., M, C., . . . L, P. (2024). Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy. World journal of urology, 42(1), 356. https://doi.org/10.1007/s00345-024-05048-4

Chicago Style (17th ed.) Citation

A, Bovo, Kwiatkowski M, Manka L, Wetterauer C, Fux CA, Cattaneo M, Wyler SF, and Prause L. "Comparison of Ciprofloxacin Versus Fosfomycin Versus Fosfomycin Plus Trimethoprim/sulfamethoxazole for Preventing Infections After Transrectal Prostate Biopsy." World Journal of Urology 42, no. 1 (2024): 356. https://doi.org/10.1007/s00345-024-05048-4.

MLA (9th ed.) Citation

A, Bovo, et al. "Comparison of Ciprofloxacin Versus Fosfomycin Versus Fosfomycin Plus Trimethoprim/sulfamethoxazole for Preventing Infections After Transrectal Prostate Biopsy." World Journal of Urology, vol. 42, no. 1, 2024, p. 356, https://doi.org/10.1007/s00345-024-05048-4.